(Q33891551)

29 July 2017

title

Systemic Therapy for Invasive Bladder Cancer (English)

1 reference

29 July 2017

1 reference

Javle M

1

1 reference

29 July 2017

Raghavan D

series ordinal

2

1 reference

29 July 2017

publication date

1 November 1996

1 reference

29 July 2017

1 reference

29 July 2017

volume

3

1 reference

29 July 2017

issue

6

1 reference

29 July 2017

page(s)

501-506

1 reference

29 July 2017

cites work

Cancer statistics, 1996.

1 reference

https://api.crossref.org/works/10.1177%2F107327489600300602

Biology and management of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327489600300602

Pre-emptive (neo-adjuvant) intravenous chemotherapy for invasive bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327489600300602

Significant activity of paclitaxel in advanced transitional-cell carcinoma of the urothelium: a phase II trial of the Eastern Cooperative Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327489600300602

A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327489600300602

Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327489600300602

M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced carcinoma of the bladder. The French Federation of Cancer Centers experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327489600300602

Initial intravenous cis-platinum therapy: improved management for invasive high risk bladder cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327489600300602

Chemotherapy before radiotherapy for T3 bladder cancer. A pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327489600300602

Neoadjuvant chemotherapy for invasive bladder cancer: prognostic factors for survival of patients treated with M-VAC with 5-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327489600300602

The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327489600300602

Adjuvant doxorubicin hydrochloride and radiation in stage D bladder cancer: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327489600300602

Radiotherapy with and without cisplatin in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327489600300602

10.1177/107327489600300602

21 January 2018

Identifiers

DOI

0 references

1 reference